More articles from Volume 52, Issue 1, 2023
SYNCOPA IN CHILDREN AND ADOLESCENTS OUR EXPERIENCE
ONE-DAY THYROID SURGERY - POSSIBILITIES AND LIMITATIONS
DEMOGRAPHIC AND CLINICAL VARIATIONS IN THE OCCURRENCE OF PEPTIC ULCER - TRENDS OVER A TEN-YEAR PERIOD
KAWASAKI DISEASE
PARANEOPLASTIC PEMPHIGUS ASSOCIATED WITH NON-HODGKIN'S LYMPHOMA: A CASE REPORT
Citations
0
KAWASAKI DISEASE
Published: 01.11.2024.
Volume 52, Issue 1 (2023)
pp. 17-22;
Abstract
Kawasaki disease (KD) is an acute, self-limited vasculitis of unknown etiology that occurs predominantly in children under the age of 5 years. In addition to the progress of modern medicine, the cause of KD is currently unknown and specific diagnostic tests for definitive diagnosis does not exist. The differential-diagnostic enigma is the exclusion of other diseases with similar clinical features. The primary treatment in the acute phase of KD is intravenous immunoglobulin (IVIG) and acetylsalicylic acid (ASA/aspirin). There is not a recommendation to a uniform therapeutic approach in refractory KD. The role of corticosteroids is still controversial, but there are studies that support its use as adjuvant treatment. Most patients have a good prognosis. The focus of future research should be the formulation of new algorithms for detection, differential diagnostic triage and treatment of KD.
Keywords
References
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
